SAN FRANCISCO (MedPage Today) -- Prolonged dual antiplatelet therapy (DAPT) after percutaneous coronary intervention did not have any clinical benefit -- and may have increased bleeding -- in two randomized trials of patients with mostly stable coronary artery disease. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment